Effect of pioglitazone on body composition and energy expenditure: A randomized controlled trial

Metabolism: Clinical and Experimental

Volumn 54, Issue 1, 2005, Pages 24-32

  Smith, Steven R ^a   De Jonge, Lilian ^a   Volaufova, Julia ^a   Li, Yinmei ^a   Xie, Hui ^a   Bray, George A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PIOGLITAZONE; PLACEBO; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGED; ARM; ARTICLE; BASAL METABOLIC RATE; BLOOD ANALYSIS; BODY COMPOSITION; BODY FAT; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HUNGER; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULINEMIA; LEG; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SATIETY; SIDE EFFECT; SUBCUTANEOUS FAT; TEST MEAL; THERMOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; TRUNK; VISUAL ANALOG SCALE; WEIGHT GAIN;

ADULT; AGED; BODY COMPOSITION; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FEMALE; HUMANS; HUNGER; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; PAIN MEASUREMENT; THIAZOLIDINEDIONES;

EID: 9644266912     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.07.008     Document Type: Article

References (26)

1. J.M. Lehmann, L.B. Moore, and T.A. Smith-Oliver An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma) J. Biol. Chem. 270 1995 12953 12956
2. E.D. Rosen, and B.M. Spiegelman PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth J. Biol. Chem. 276 2001 37731 37734
3. T. Yamauchi, J. Kamon, and H. Waki The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance J. Biol. Chem. 276 2001 41245 41254
4. A. Okuno, H. Tamemoto, and K. Tobe Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats J. Clin. Invest. 101 1998 1354 1361
5. S. Hallakou, L. Doare, and F. Foufelle Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat Diabetes 46 1997 1393 1399
6. S. Akazawa, F. Sun, and M. Ito Efficacy of troglitazone on body fat distribution in type 2 diabetes Diabetes Care 23 2000 1067 1071
7. Y. Mori, Y. Murakawa, and K. Okada Effect of troglitazone on body fat distribution in type 2 diabetic patients Diabetes Care 22 1999 908 912
8. I.E. Kelly, T.S. Han, and K. Walsh Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes [published erratum appears in Diabetes Care 1999 Mar;22(3):536] Diabetes Care 22 1999 288 293
9. A.M. Lefebvre, M. Laville, and N. Vega Depot-specific differences in adipose tissue gene expression in lean and obese subjects Diabetes 47 1998 98 103
10. B.A. Neuschwander-Tetri, E.M. Brunt, and K.R. Wehmeier Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone Hepatology 38 2003 1008 1017
11. M. Bajaj, S. Suraamornkul, and T. Pratipanawatr Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes Diabetes 52 2003 1364 1370
12. M.J. Franz, J.P. Bantle, and C.A. Beebe Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications Diabetes Care 25 2002 148 198
13. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J. Clin. Endocrinol. Metab. 85 2000 2402 2410
14. H. Chen, G. Sullivan, and L.Q. Yue QUICKI is a useful index of insulin sensitivity in subjects with hypertension Am. J. Physiol. Endocrinol. Metab. 284 2003 E804 E812
15. S.R. Smith, J.C. Lovejoy, and F. Greenway Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity Metabolism 50 2001 425 435
16. Energy and protein requirements. Report of a Joint FAO/WHO UNU Meeting. WHO Technical Report Series, 724. Geneva: World Health Organisation; 1985.
17. M. Elia, and G. Livesey Theory and validity of indirect calorimetry during net lipid synthesis Am. J. Clin. Nutr. 47 1988 591 607
18. A.B. King, D.U. Armstrong, and S. Chinnapongse Clinical observations of weight gain associated with pioglitazone: 3 years American Diabetes Association 63rd Scientific Sessions: New Orleans, LA; 2003 2003
19. H. Kvist, L. Sjostrom, and U. Tylen Adipose tissue volume determinations in women by computed tomography: technical considerations Int. J. Obes. 10 1986 53 67
20. S.R. Smith Regional fat distribution G.A. Bray D.H. Ryan Nutrition genetic and obesity vol. 9 1999 LSU Press Baton Rouge (LA) 433 458
21. T.P. Ciaraldi, B.S. Cha, and K.S. Park Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonists Ann. N. Y. Acad. Sci. 967 2002 66 70
22. S. Katoh, S. Hata, and M. Matsushima Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy-a randomized controlled trial Metabolism 50 2001 414 417
23. H. Hirose, T. Kawai, and Y. Yamamoto Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes Metabolism 51 2002 314 317
24. Y. Miyazaki, A. Mahankali, and M. Matsuda Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients J. Clin. Endocrinol. Metab. 87 2002 2784 2791
25. S. Fullert, F. Schneider, and E. Haak Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study J. Clin. Endocrinol. Metab. 87 2002 5503 5506
26. A.B. Mayerson, R.S. Hundal, and S. Dufour The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes Diabetes 51 2002 797 802